Vanguard Group Inc. Takes $25.90 Million Position in Grail, Inc. (NASDAQ:GRAL)

Vanguard Group Inc. bought a new position in Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 1,451,095 shares of the company's stock, valued at approximately $25,902,000. Vanguard Group Inc. owned approximately 4.32% of Grail as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in GRAL. FNY Investment Advisers LLC bought a new stake in Grail during the fourth quarter worth about $26,000. Lindbrook Capital LLC bought a new stake in Grail in the 4th quarter worth approximately $28,000. Wellington Shields Capital Management LLC bought a new stake in Grail in the 4th quarter worth approximately $33,000. New York State Common Retirement Fund purchased a new stake in Grail in the fourth quarter worth approximately $59,000. Finally, Wilmington Savings Fund Society FSB bought a new position in Grail during the fourth quarter valued at approximately $64,000.

Grail Trading Up 6.8 %

GRAL opened at $24.85 on Tuesday. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The business's 50-day moving average price is $33.33 and its 200-day moving average price is $23.34.

Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating analysts' consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. On average, equities analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley boosted their price objective on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th.

Remove Ads

Insider Transactions at Grail

In other Grail news, CEO Robert P. Ragusa sold 7,625 shares of the firm's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the sale, the chief executive officer now directly owns 828,662 shares in the company, valued at $25,862,541.02. This trade represents a 0.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Aaron Freidin sold 1,816 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the transaction, the chief financial officer now owns 335,170 shares of the company's stock, valued at approximately $10,457,304. The trade was a 0.54 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,550 shares of company stock worth $360,436.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.